Reducing the Risk of Recurrences after Pulmonary Vein Isolation: What Is the Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers?

Publisher： Karger

E-ISSN： 1421-9751|117|1|11-13

ISSN： 0008-6312

Source： Cardiology, Vol.117, Iss.1, 2010-09, pp. : 11-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Impact of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on the Long-Term Outcome after Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

By  

Cardiology, Vol. 117, Iss. 1, 2010-09 ,pp. : 14-20

Karger

Access to resources Recommend Favorite

Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 38, Iss. 1, 2018-01 ,pp. : 29-41

John Wiley & Sons Inc

Access to resources Recommend Favorite

From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors

By  

Cardiology, Vol. 117, Iss. 3, 2010-11 ,pp. : 163-173

Karger

Access to resources Recommend Favorite

Protocol

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 3, 2015-04 ,pp. : 452-456

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors as a Risk Factor for Contrast-Induced Nephropathy

By  

Nephron Clin Pract, Vol. 104, Iss. 1, 2006-05 ,pp. : c20-c27

Karger

Access to resources Recommend Favorite